These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 19587470)

  • 1. Once daily baclofen sustained release or gastro-retentive system are acceptable alternatives to thrice daily baclofen immediate release at same daily dosage in patients.
    Sampat NG; Kulkarni RV; Sase N; Joshi NH; Vora PB; Bhattacharya AK; Lakhani JD; Bhowmik SS
    Neurol India; 2009; 57(3):295-9. PubMed ID: 19587470
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of clinical and neurophysiologic responses to intrathecal baclofen bolus administration in moderate-to-severe spasticity after acquired brain injury.
    Stokic DS; Yablon SA; Hayes A
    Arch Phys Med Rehabil; 2005 Sep; 86(9):1801-6. PubMed ID: 16181946
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prospective assessment of tizanidine for spasticity due to acquired brain injury.
    Meythaler JM; Guin-Renfroe S; Johnson A; Brunner RM
    Arch Phys Med Rehabil; 2001 Sep; 82(9):1155-63. PubMed ID: 11552184
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intrathecal baclofen therapy for severe spasticity: analysis on a series of 112 consecutive patients and future prospectives.
    Natale M; Mirone G; Rotondo M; Moraci A
    Clin Neurol Neurosurg; 2012 May; 114(4):321-5. PubMed ID: 22104692
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety study of arbaclofen placarbil in patients with spasticity due to spinal cord injury.
    Nance PW; Huff FJ; Martinez-Arizala A; Ayyoub Z; Chen D; Bian A; Stamler D
    Spinal Cord; 2011 Sep; 49(9):974-80. PubMed ID: 21577221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcomes of intrathecal baclofen (ITB) therapy in spacticity.
    Ucar T; Kazan S; Turgut U; Samanci NK
    Turk Neurosurg; 2011 Jan; 21(1):59-65. PubMed ID: 21294093
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of hydrotherapy for the management of spasticity.
    Kesiktas N; Paker N; Erdogan N; Gülsen G; Biçki D; Yilmaz H
    Neurorehabil Neural Repair; 2004 Dec; 18(4):268-73. PubMed ID: 15537997
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional outcome of intrathecal baclofen administration for severe spasticity.
    Boviatsis EJ; Kouyialis AT; Korfias S; Sakas DE
    Clin Neurol Neurosurg; 2005 Jun; 107(4):289-95. PubMed ID: 15885386
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intrathecal baclofen for spastic hypertonia from stroke.
    Meythaler JM; Guin-Renfroe S; Brunner RC; Hadley MN
    Stroke; 2001 Sep; 32(9):2099-109. PubMed ID: 11546903
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A clinical study of intrathecal baclofen using a programmable pump for intractable spasticity.
    Guillaume D; Van Havenbergh A; Vloeberghs M; Vidal J; Roeste G
    Arch Phys Med Rehabil; 2005 Nov; 86(11):2165-71. PubMed ID: 16271565
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and tolerability of cyclobenzaprine extended release for acute muscle spasm: a pooled analysis.
    Weil AJ; Ruoff GE; Nalamachu S; Altman CA; Xie F; Taylor DR
    Postgrad Med; 2010 Jul; 122(4):158-69. PubMed ID: 20675978
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complex dosing schedules for continuous intrathecal baclofen infusion.
    Krach LE; Kriel RL; Nugent AC
    Pediatr Neurol; 2007 Nov; 37(5):354-9. PubMed ID: 17950422
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Continuously infused intrathecal baclofen over 12 months for spastic hypertonia in adolescents and adults with cerebral palsy.
    Meythaler JM; Guin-Renfroe S; Law C; Grabb P; Hadley MN
    Arch Phys Med Rehabil; 2001 Feb; 82(2):155-61. PubMed ID: 11239304
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intrathecal baclofen for treatment of intractable spinal spasticity.
    Abel NA; Smith RA
    Arch Phys Med Rehabil; 1994 Jan; 75(1):54-8. PubMed ID: 8291963
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dose conversion between tapentadol immediate and extended release for low back pain.
    Etropolski MS; Okamoto A; Shapiro DY; Rauschkolb C
    Pain Physician; 2010; 13(1):61-70. PubMed ID: 20119464
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intrathecal baclofen for severe spinal spasticity.
    Penn RD; Savoy SM; Corcos D; Latash M; Gottlieb G; Parke B; Kroin JS
    N Engl J Med; 1989 Jun; 320(23):1517-21. PubMed ID: 2657424
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of intrathecal baclofen on daily care in children with secondary generalized dystonia: a pilot study.
    Bonouvrié LA; van Schie PE; Becher JG; van Ouwerkerk WJ; Reeuwijk A; Jeroen Vermeulen R
    Eur J Paediatr Neurol; 2011 Nov; 15(6):539-43. PubMed ID: 21628102
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Time course of the effect of a bolus dose of intrathecal baclofen on severe cerebral spasticity.
    Pohl M; Rockstroh G; Rückriem S; Mehrholz J; Pause M; Koch R; Strik H
    J Neurol; 2003 Oct; 250(10):1195-200. PubMed ID: 14586601
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and tolerability of eperisone and baclofen in spastic palsy: a double-blind randomized trial.
    Bresolin N; Zucca C; Pecori A
    Adv Ther; 2009 May; 26(5):563-73. PubMed ID: 19458926
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Self-reported sedation profile of quetiapine extended-release and quetiapine immediate-release during 6-day initial dose escalation in bipolar depression: a multicenter, randomized, double-blind, phase IV study.
    Riesenberg RA; Baldytcheva I; Datto C
    Clin Ther; 2012 Nov; 34(11):2202-11. PubMed ID: 23059166
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.